2005
DOI: 10.4049/jimmunol.175.11.7719
|View full text |Cite
|
Sign up to set email alerts
|

Staphylococcal Protein A Deletes B-1a and Marginal Zone B Lymphocytes Expressing Human Immunoglobulins: An Immune Evasion Mechanism

Abstract: Protein A (SpA) of Staphylococcus aureus is endowed with the capacity to interact with the H chain variable region (VH) of human Abs and to target >40% of B lymphocytes. To investigate whether this property represents a virulence factor and to determine the in vivo consequences of the confrontation of SpA with B lymphocytes, we used transgenic mice expressing fully human Abs. We found that administration of soluble SpA reduces B-1a lymphocytes of the peritoneal cavity and marginal zone B lymphocytes of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
24
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 33 publications
(25 citation statements)
references
References 52 publications
1
24
0
Order By: Relevance
“…Other groups have convincingly demonstrated that SpA specifically triggers the apoptosis of V H 3-BCR ϩ B cells (18,69,70). In line with these studies, we observe that SpA alone fails to induce B cell proliferation (Fig.…”
Section: Discussionsupporting
confidence: 90%
“…Other groups have convincingly demonstrated that SpA specifically triggers the apoptosis of V H 3-BCR ϩ B cells (18,69,70). In line with these studies, we observe that SpA alone fails to induce B cell proliferation (Fig.…”
Section: Discussionsupporting
confidence: 90%
“…Yet, the observations summarized above and obtained in a model of mice expressing human Igs (Viau et al, 2004a,b, 2005, 2007; Viau and Zouali, 2005) and in a non-human primate (Peruchon et al, 2009) revealed that viruses and bacteria have developed strategies to deplete MZ B-cells during the acute phase of infection. Unraveling the intimate mechanisms responsible for targeting MZ B-cells in humans and non-human primates will be important for understanding disease pathogenesis and for designing novel vaccine formulations.…”
Section: Discussionmentioning
confidence: 99%
“…It would be of interest to compare the levels and activities of signaling molecules downstream of TLR4/MD-2, RP105/MD-1, and the BCR in MZB and FOB cells, although such biochemical studies would likely be technically challenging due to the limited number of MZB cells per mouse. Profiling the signaling capacity of these B cell subsets might also yield insight into the molecular mechanisms that underlie the enhanced sensitivity of MZB cells to bacterial B cell superantigens (41,42).…”
Section: Discussionmentioning
confidence: 99%